Scientists watch EBV wake up in healthy young people
NCT ID NCT07536048
First seen Apr 17, 2026 · Last updated Jun 19, 2026 · Updated 9 times
Summary
This study follows about 100 healthy adults aged 18 to 29 who have had Epstein-Barr virus (EBV) in the past. Researchers collect blood and saliva samples over 6 to 12 months to see when the virus becomes active again and how the immune system responds. No treatments or vaccines are given—the goal is simply to gather information.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Griffith - University Clinical Trial Unit - Site Number : 0360001
Gold Coast, 4222, Australia
-
University of Sunshine Coast - Site Number : 0360002
South Brisbane, 4101, Australia
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this study could help researchers understand why EBV reactivates and how the immune system responds, potentially guiding future treatments or vaccines.
What could go wrong
This is an observational study with no intervention, so it won't directly test any treatment. It is small (100 participants) and only follows people for up to a year, which may limit how much we learn.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.